INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.73B / 25S · 14 late98 trades$31.71M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,650 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
SK
Sidow Kevin K.Director
SISHOULDER INNOVATIONS, INC.
Grant or award
A—
5,046 sh
Jun 26, 2026Jun 29, 2026
Page 602 of 1717
← PrevNext →
traded Jun 26, 2026
+3d
SEC Form 4

Evidence

17
LR
Lechleider RobertChief Medical Officer
IMNMImmunome Inc.
Option exercise · 10b5-1 plan
M$480K
55.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

16
LM
Lockett Phyllis MDirector
CMECME GROUP INC.
Grant or award
A$145K
645 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

16
SR
Seifu RahaelDirector
CMECME GROUP INC.
Grant or award
A$145K
645 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$104K
18.1K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

16
MW
Maloney Patrick WDirector
CMECME GROUP INC.
Grant or award
A$145K
645 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$186K
31.9K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

15
LM
Locke MistelleDirector
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
159 sh
Jun 9, 2026Jun 29, 2026
traded Jun 9, 2026
+20dSEC Form 4

Evidence

15
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$298K
11.4K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

15
LM
Locke MistelleDirector
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
37 sh
Jun 12, 2026Jun 29, 2026
traded Jun 12, 2026
+17dSEC Form 4

Evidence

15
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$33K
100 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

15
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$17K
50 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

15
LR
Leatherberry Antoinette ReneeDirector
DRCTDirect Digital Holdings, Inc.
Option exercise
M—
37 sh
Jun 12, 2026Jun 29, 2026
traded Jun 12, 2026
+17dSEC Form 4

Evidence

15
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$17K
50 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

14
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$66K
200 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

14
WD
Walker Mark DDirector, Chairman and CEO
DRCTDirect Digital Holdings, Inc.
Tax withholding · 10b5-1 plan
F$65.8
20 sh
Apr 1, 2026Jun 29, 2026
traded Apr 1, 2026
+89dSEC Form 4

Evidence

14
WD
Walker Mark DDirector, Chairman and CEO
DRCTDirect Digital Holdings, Inc.
Tax withholding · 10b5-1 plan
F$49.28
14 sh
Mar 20, 2026Jun 29, 2026
traded Mar 20, 2026
+101dSEC Form 4

Evidence

13
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$7,826
1,373 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

13
PB
Parker Stuart B.Director
HQYHEALTHEQUITY, INC.
Grant or award
A—
2,877 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

13
NR
Natarajan RajeshDirector
HQYHEALTHEQUITY, INC.
Grant or award
A—
2,877 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

13
GG
Geanakos Jonathan G.Director
NONENONESculptor Diversified Real Estate Income Trust, Inc.
Grant or award
A—
2,142 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

13
HH
Helmersson HelenaDirector
ONONOn Holding AG
Tax withholding
F$17K
452 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

13
RW
Rogers James WilliamChief Financial Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$634K
11.5K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

13
DA
Doudna Jennifer ADirector
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$147K
2,673 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

13
WF
Wellborn Gayle FurgursonDirector
HQYHEALTHEQUITY, INC.
Grant or award
A—
2,877 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

12
MJ
Mulchrone Patrick JDirector
CMECME GROUP INC.
Grant or award
A$145K
645 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

12
TJ
Tierney Robert J JRDirector
CMECME GROUP INC.
Grant or award
A$145K
645 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

12
FR
Friesner RichardDirector
SDGRSchrodinger, Inc.
Gift
G—
679.4K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

12
FR
Friesner RichardDirector
SDGRSchrodinger, Inc.
Gift
G—
679.4K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

10
WD
Walker Mark DDirector, Chairman and CEO
DRCTDirect Digital Holdings, Inc.
Option exercise · 10b5-1 plan
M—
204 sh
Jan 24, 2026Jun 29, 2026
traded Jan 24, 2026
+156dSEC Form 4

Evidence

10
WD
Walker Mark DDirector, Chairman and CEO
DRCTDirect Digital Holdings, Inc.
Option exercise · 10b5-1 plan
M—
204 sh
Jan 24, 2026Jun 29, 2026
traded Jan 24, 2026
+156dSEC Form 4

Evidence

10
WD
Walker Mark DDirector, Chairman and CEO
DRCTDirect Digital Holdings, Inc.
Grant or award · 10b5-1 plan
A—
8,750 sh
Mar 24, 2026Jun 29, 2026
traded Mar 24, 2026
+97dSEC Form 4

Evidence

10
WD
Walker Mark DDirector, Chairman and CEO
DRCTDirect Digital Holdings, Inc.
Option exercise · 10b5-1 plan
M—
45 sh
Mar 20, 2026Jun 29, 2026
traded Mar 20, 2026
+101dSEC Form 4

Evidence

9
BA
Borden William A.Director
SOFISoFi Technologies, Inc.
Grant or award
A—
1,016 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
AA
Anderson Craig A.SVP and Controller
JXNJackson Financial Inc.
Grant or award
A—
29 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CW
Cummings Don WEVP and CFO
JXNJackson Financial Inc.
Grant or award
A—
55 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
BP
Botteri PhilippeDirector
PATHUiPath, Inc.
Grant or award
A—
19.2K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
GD
Goldberg Andrew D.Director
TARSTarsus Pharmaceuticals, Inc.
Grant or award
A—
2,417 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Grant or award
A—
31 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
JR
Jain RitaDirector
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
26.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence